Appendix Table C69Eye symptom outcomes: change from baseline–combination oral selective antihistamine plus oral decongestant versus oral selective antihistamine

Author, YearDrug, Dose/DayN/nTime, weeksOutcomeBaseline meanChange from baselinep
Grosclaude, 1997Cetirizine 10 mg/Pseudoephedrine 240 mg227/2272Itching eyes1.68-1.01a
Cetirizine 10 mg231/2311.83-1.02 aNS
Sussman, 1999Fexofenadrine 120 mg/Pseudoephedrine 240 mg215/2152.6Itchy, watery, red eyesNR-0.6 b,c
Fexofenadrine 120 mg218/218NR-0.5 b,cNR

N/n, number randomized/number analyzed

a

4-point scale: 0, absent; 1, mild; 2, moderate; 3, severe.

b

5-point scale: 0, absent; 1, mild; 2, moderate; 3, severe; 4, very severe

c

Values obtained using Engauge Digitizer Software

4-point scale: 0, absent; 1, mild; 2, moderate; 3, severe.

5-point scale: 0, absent; 1, mild; 2, moderate; 3, severe; 4, very severe

Values obtained using Engauge Digitizer Software

From: Appendix C, Evidence Tables

Cover of Treatments for Seasonal Allergic Rhinitis
Treatments for Seasonal Allergic Rhinitis [Internet].
Comparative Effectiveness Reviews, No. 120.
Glacy J, Putnam K, Godfrey S, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.